Find News

Filter articles

Showing 2371 to 2380 of 2541 results

Battistelli buoyant on Unitary Patent


European Patent Office president Benoît Battistelli has praised the “steady” progress that the Unitary Patent and its associated court have made this year.

FDA approves first generic versions of Lilly’s $5bn Cymbalta


The US Food and Drug Administration (FDA) has approved the first generic versions of antidepressant drug Cymbalta (duloxetine hydrochloride), after Eli Lilly’s primary patent covering the product expired on December 11.

Davis LLP bolsters life sciences team


Canadian law firm Davis LLP has strengthened its life sciences department with the addition of Sara Zborovski as partner.

Australian High Court says medical treatment methods are patentable


The High Court in Australia has said for the first time that a method of medical treatment for the human body can be a patentable invention.

Politicians plead with Obama over TPP drug rules


Six US congressman have implored President Barack Obama to ensure that the Trans Pacific Partnership does not include measures that undermine access to affordable healthcare.

Major chemical patent database launched


Europe’s main life sciences laboratory has made a database containing details of around 15 million patented chemical structures available to the public for the first time.

IP Summit: life sciences IP challenges


The rapidly-evolving field of life sciences presents a variety of unique IP challenges, which were debated at this year's PanEuropean IP Summit in Paris.

IP Summit: What does the UPC hold for the pharma and chemical industries?


At the PanEuropean IP Summit on Tuesday, a panel discussion revealed different attitudes toward the introduction of the Unitary Patent and Unified Patent Court.

C5 Congress: Patenting natural products after Myriad


Speaking at Wednesday's C5 Congress on Biotech and Pharma Patenting in London, Michael McGraw, a partner from Fitzpatrick, Cella, Harper and Scinto in New York, considered the line that separates natural and man-made products.

C5 Forum on Biosimilars: the importance of regulation


At the 3rd C5 Forum on Biosimilars in London on Wednesday, a panel of lawyers and regulatory experts discussed the lie of the land for biosimilars.

Showing 2371 to 2380 of 2541 results